This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Dec;15(12):1925-6.

doi: 10.1002/ibd.20973. Epub 2009 May 21.

Targeting TNF in postoperative recurrence of Crohn's disease: can we extinguish the fire before it starts?

Glen A Doherty¹, Adam S Cheifetz

Affiliations

Affiliation

¹ Center for Inflammatory Bowel Disease, Division of Gastroenterology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.

PMID: 19462427
DOI: 10.1002/ibd.20973

Comment

Targeting TNF in postoperative recurrence of Crohn's disease: can we extinguish the fire before it starts?

Glen A Doherty et al. Inflamm Bowel Dis. 2009 Dec.

. 2009 Dec;15(12):1925-6.

doi: 10.1002/ibd.20973. Epub 2009 May 21.

Authors

Glen A Doherty¹, Adam S Cheifetz

Affiliation

¹ Center for Inflammatory Bowel Disease, Division of Gastroenterology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.

PMID: 19462427
DOI: 10.1002/ibd.20973

No abstract available

PubMed Disclaimer

Comment on

Infliximab prevents Crohn's disease recurrence after ileal resection.
Regueiro M, Schraut W, Baidoo L, Kip KE, Sepulveda AR, Pesci M, Harrison J, Plevy SE. Regueiro M, et al. Gastroenterology. 2009 Feb;136(2):441-50.e1; quiz 716. doi: 10.1053/j.gastro.2008.10.051. Epub 2008 Oct 31. Gastroenterology. 2009. PMID: 19109962 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.